{"count":217,"next":null,"previous":"https://memento.epfl.ch/api/v1/events/?format=json&limit=10&offset=200&ordering=-event__speaker","results":[{"id":71922,"title":"U.S. CDMRP – Alzheimer's Research Program | Research Funding","slug":"us-cdmrp-alzheimer-s-research-program-research-fun","event_url":"https://memento.epfl.ch/event/us-cdmrp-alzheimer-s-research-program-research-fun","visual_url":"https://memento.epfl.ch/image/33239/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33239/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33239/max-size.jpg","lang":"en","start_date":"2026-06-22","end_date":"2026-06-22","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Alzheimer's Research Program (AZRP) </strong>Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Transforming Care Award </strong>aims to support well-designed, non-incremental clinical research that develops and implements interventions, innovations, and solutions to address critical challenges in dementia care. Projects should lead to improved quality of life, reduced caregiver burden and stress, and enhanced care delivery and outcomes for individuals living with AD/ADRD.</li>\r\n\t<li>The <strong>Transforming Diagnosis Award </strong>supports non-incremental, solution-oriented research that addresses critical barriers to timely and accurate diagnosis, disease monitoring, and prognosis in AD/ADRD. Projects should demonstrate clear potential to improve accessibility, clinical implementation, and the reliability of diagnostic and prognostic approaches.</li>\r\n\t<li>The <strong>Transforming Research Award </strong>supports non-incremental, high-impact research that aims to drive transformative advances in reducing risk and preventing the development of AD/ADRD. Projects should demonstrate strong potential to accelerate prevention strategies and deliver meaningful improvements in patient outcomes and quality of life.<strong> </strong>All projects must respond to one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241238&amp;fileType=pdf\">here</a>.</li>\r\n</ul>\r\n<strong>Funding</strong>:\r\n\r\n<ul>\r\n\t<li>Transforming Care Award: $1.6M - $1.9M</li>\r\n\t<li>Transforming Diagnosis Award: $1.5M - $1.7M</li>\r\n\t<li>Transforming Research Award: max. $1M</li>\r\n</ul>\r\n<br>\r\n<sub>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sub><br>\r\n<br>\r\n<br>\r\n<strong>Duration</strong>:   \r\n\r\n<ul>\r\n\t<li>Transforming Care Award: 4 years</li>\r\n\t<li>Transforming Diagnosis Award: 4 years</li>\r\n\t<li>Transforming Research Award: 3 years</li>\r\n</ul>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Program-specific seniority levels and eligibility criteria are further defined within each award mechanism <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36243245&amp;fileType=pdf\">here</a>.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 22 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>24 September 2026</strong>, 11:59 p.m Eastern Time<br>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719106\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36243245&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a></li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Transforming Care Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241229&amp;fileType=pdf\">HT942526AZRPTRCA</a></li>\r\n\t\t<li>Transforming Diagnosis Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241231&amp;fileType=pdf\">HT942526AZRPTRDA</a></li>\r\n\t\t<li>Transforming Research Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241238&amp;fileType=pdf\">HT942526AZRPTRRA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>","image_description":"","creation_date":"2026-05-21T16:12:42","last_modification_date":"2026-05-21T16:12:42","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120829/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71934,"title":"Future of Health Grant","slug":"future-of-health-grant-3","event_url":"https://memento.epfl.ch/event/future-of-health-grant-3","visual_url":"https://memento.epfl.ch/image/33245/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33245/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33245/max-size.jpg","lang":"en","start_date":"2026-07-31","end_date":"2026-07-31","start_time":"11:00:00","end_time":"12:00:00","description":"<p>The <strong>Future of Health Grant</strong> is a support program dedicated to accelerating early‑stage digital health startups developing solutions relevant to the Swiss healthcare system.<br>\r\nCreated by CSS and the EPFL Innovation Park, it combines equity‑free funding, expert guidance and access to healthcare stakeholders to help founders progress from prototype to real‑world validation.<br>\r\n<br>\r\n<strong>For whom</strong>\r\n</p><ul>\r\n\t<li>For early‑stage digital health startups developing solutions that can be applied within the Swiss healthcare system.</li>\r\n\t<li>Eligible teams may be based in Switzerland or abroad, provided their innovation is relevant to Swiss clinical, operational or preventive care contexts.</li>\r\n\t<li>The program targets founders at the prototype, MVP or early validation stage.</li>\r\n</ul>\r\n<strong>What you gain</strong>\r\n\r\n<ul>\r\n\t<li><strong>equity‑free financial support</strong> at three possible levels (CHF 10k, 30k or 50k), depending on project maturity and needs</li>\r\n\t<li>teams benefit from <strong>structured coaching</strong>, <strong>industry mentoring</strong></li>\r\n\t<li>access to <strong>paid specialists</strong> through the “CxO as a Service” model</li>\r\n\t<li>The program also facilitates <strong>real‑world validation</strong> opportunities with healthcare professionals, hospitals, insurers and ecosystem partners in Switzerland</li>\r\n</ul>\r\n<strong>How it works</strong><br>\r\n<br>\r\nThe program operates fully virtually and follows a milestone‑based approach. Selected startups receive regular guidance from experts in digital health, business development and regulatory pathways. Each team works toward defined objectives, with progress reviewed at set intervals. The program supports founders in strengthening their product, business model and clinical relevance.<br>\r\n<strong>Program context</strong><br>\r\n<br>\r\nLaunched in 2022, the Future of Health Grant is an initiative of <strong>CSS</strong> and the <strong>EPFL Innovation Park</strong>. Its mission is to accelerate the adoption of impactful digital health solutions by bridging early‑stage innovation with the needs of real healthcare systems.","image_description":"","creation_date":"2026-05-22T13:39:38","last_modification_date":"2026-05-22T13:39:44","link_label":"Webpage","link_url":"https://future-of-health.org/","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"<a href=\"https://future-of-health.org/\">Future of Health Grant</a>, a programm powered by Fondation EPFL Innovation Park","contact":"Mathilde Durvy <a href=\"mailto:info@fohg.ch\">info@fohg.ch</a>","is_internal":"False","theme":"","vulgarization":{"id":2,"fr_label":"Public averti","en_label":"Informed public"},"registration":{"id":1,"fr_label":"Sur inscription","en_label":"Registration required"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120842/","category":{"id":17,"code":"DEADLINE","fr_label":"Echéance","en_label":"Deadline","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/422/?format=json"]},{"id":71945,"title":"OpenPulse Community Rollout Workshop: Making Research Software Visible and Valued","slug":"openpulse-community-rollout-workshop-making-resear","event_url":"https://memento.epfl.ch/event/openpulse-community-rollout-workshop-making-resear","visual_url":"https://memento.epfl.ch/image/33252/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33252/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33252/max-size.jpg","lang":"en","start_date":"2026-06-16","end_date":"2026-06-16","start_time":"09:30:00","end_time":"13:30:00","description":"<strong>Open-source research software has become a central part of how modern science is produced, shared, and reused. Yet the work involved in developing, maintaining, documenting, and sustaining research software communities often remains difficult to see, measure, and value within research institutions.</strong><br>\r\n<br>\r\nOpenPulse is an open research data platform developed by <a href=\"https://www.epfl.ch/research/open-science/\">EPFL Open Science</a> in collaboration with the <a href=\"https://www.datascience.ch/\">Swiss Data Science Center</a>. It aims to make research software communities and their contributions more visible and valued through meaningful indicators related to activity, collaboration, maintenance, and community engagement around software.<br>\r\n<br>\r\nAt the first OpenPulse event in November 2025, participants helped us think through what such a platform could make possible. Through a hands-on sprint, they prototyped ideas around open hardware, reproducible machine learning, open education, data visualization, and open-source policy and governance.<br>\r\n<br>\r\n<strong>Now, OpenPulse is ready for its community rollout.</strong><br>\r\n<br>\r\nThis follow-up workshop invites the community to try out the dashboards, examine research software projects through a first set of <a href=\"https://chaoss.community/kbtopic/all-metrics/\">CHAOSS</a>-inspired indicators, share feedback, and discuss what we can learn from looking at research software through the lens of community engagement.<br>\r\n<br>\r\nWe welcome researchers, software developers, research software engineers, data scientists, research administrators, IT and library professionals, and anyone interested in how research software communities are built, maintained, evaluated, and supported. No coding experience is required. Technical, conceptual, strategic, and community perspectives are equally welcome.<br>\r\n<br>\r\n<strong>Programme highlights</strong>\r\n<ul>\r\n\t<li>Introduction: <em>What do open-source research software communities look like, and why study them through the lens of community engagement?</em></li>\r\n\t<li>Live OpenPulse demo by the Swiss Data Science Center</li>\r\n\t<li>OpenPulse booth &amp; hands-on dashboard exploration</li>\r\n\t<li>Community roundtable on OpenPulse governance, maintenance, and sustainability.\r\n\t<ul>\r\n\t\t<li>Together, we will ask: <em>How do research software communities grow and sustain themselves?</em> <em>How are decisions made? Who maintains pull requests and bug trackers? What kinds of contributions are visible, and which ones are still missed?</em></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Lunch discussion and closing remarks</li>\r\n</ul>\r\nSpots are limited. <a href=\"https://docs.google.com/forms/d/e/1FAIpQLScyzPCwyCmLPay_liv0mEIl4lliQy6XGkj6jVhq88OopwZ92A/viewform?usp=header\"><strong>Register Now </strong></a>and be part of the OpenPulse launch.<br>\r\nFor more information, please contact: <strong><a data-end=\"2822\" data-start=\"2803\" rel=\"noopener\">openscience@epfl.ch</a></strong>","image_description":"OpenPulse mini hackathon, November 2025","creation_date":"2026-05-26T14:56:06","last_modification_date":"2026-05-27T10:04:15","link_label":"Registration","link_url":"https://docs.google.com/forms/d/e/1FAIpQLScyzPCwyCmLPay_liv0mEIl4lliQy6XGkj6jVhq88OopwZ92A/viewform?usp=header","canceled":"False","cancel_reason":"","place_and_room":"BIO_A 6 201, Biopôle, Lausanne","url_place_and_room":"https://plan.epfl.ch/?room==BIO_A%206%20201","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"A joint event by: <a href=\"https://www.epfl.ch/research/open-science/\">EPFL Open Science</a>, <a href=\"https://www.epfl.ch/schools/enac/about/data-at-enac/enac-it4research/\">ENAC-IT4R</a>, and <a href=\"https://www.datascience.ch/\">SDSC</a>","contact":"openscience@epfl.ch","is_internal":"False","theme":"","vulgarization":{"id":3,"fr_label":"Expert","en_label":"Expert"},"registration":{"id":1,"fr_label":"Sur inscription","en_label":"Registration required"},"keywords":"Open-Source, Research Software, Community, Open Research Data, Open Science","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120857/","category":{"id":1,"code":"CONF","fr_label":"Conférences - Séminaires","en_label":"Conferences - Seminars","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/3/?format=json","https://memento.epfl.ch/api/v1/mementos/5/?format=json","https://memento.epfl.ch/api/v1/mementos/6/?format=json","https://memento.epfl.ch/api/v1/mementos/8/?format=json","https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/27/?format=json","https://memento.epfl.ch/api/v1/mementos/111/?format=json","https://memento.epfl.ch/api/v1/mementos/412/?format=json","https://memento.epfl.ch/api/v1/mementos/416/?format=json","https://memento.epfl.ch/api/v1/mementos/432/?format=json"]},{"id":71948,"title":"U.S. CDMRP – Lung Cancer Research Program | Research Funding","slug":"us-cdmrp-lung-cancer-research-program-research-f-6","event_url":"https://memento.epfl.ch/event/us-cdmrp-lung-cancer-research-program-research-f-6","visual_url":"https://memento.epfl.ch/image/33256/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33256/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33256/max-size.jpg","lang":"en","start_date":"2026-06-23","end_date":"2026-06-23","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Lung Cancer Research Program</strong> <strong>(LCRP)</strong> Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Idea Development Award</strong> Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research.</li>\r\n\t<li>The <strong>Patient-Centered Outcomes and Survivorship Award</strong> Supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications.</li>\r\n\t<li>The <strong>Translational Research Award</strong> mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application.</li>\r\n</ul>\r\nAll applications for LCRP funding must specifically address at least one of the <strong>Areas of Emphasis</strong>. The FY26 LCRP Areas are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>:      <br>\r\nIdea Development Award: max. $800K<br>\r\nPatient-Centered Outcomes and Survivorship Award: max. $975K<br>\r\nTranslational Research Award: $1.35M – $1.85M<br>\r\n<sup><sub>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sub></sup><br>\r\n<br>\r\n<strong>Duration</strong>:   <br>\r\nIdea Development Award: 3 years<br>\r\nPatient-Centered Outcomes and Survivorship Award: 3 years<br>\r\nTranslational Research Award: 3-4 years<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Program-specific seniority levels and eligibility criteria are further defined within each award mechanism <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221239&amp;fileType=pdf\">here</a>.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline:          </strong>\r\n\r\n<ul>\r\n\t<li><strong>23 June 2026, </strong>5:00 p.m. Eastern time\r\n\r\n\t<ul>\r\n\t\t<li>Idea Development Award</li>\r\n\t\t<li>Translational Research Award</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><strong>18 August 2026, </strong>5:00 p.m. Eastern time\r\n\t<ul>\r\n\t\t<li>Patient-Centered Outcomes and Survivorship Award</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<strong>Full Application Deadline for all calls</strong>:\r\n\r\n<ul>\r\n\t<li><strong>02 September 2026</strong>, 11:59 p.m Eastern Time</li>\r\n</ul>\r\n         <br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719103\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221239&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a></li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Idea Development Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221233&amp;fileType=pdf\">HT942526LCRPIDA</a></li>\r\n\t\t<li>Patient-Centered Outcomes and Survivorship Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221308&amp;fileType=pdf\">HT942526LCRPPCOSA</a></li>\r\n\t\t<li>Translational Research Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221292&amp;fileType=pdf\">HT942526LCRPTRA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<br>\r\n<strong>FY26 LCRP Areas of Emphasis</strong>\r\n\r\n<ul>\r\n\t<li>Biology and Etiology\r\n\t<ul>\r\n\t\t<li>Understand the molecular mechanisms of initiation and progression of pre-malignancy to lung cancer.</li>\r\n\t\t<li>Understand contributors to lung cancer development other than tobacco, including hereditary and sex-specific differences.</li>\r\n\t\t<li>Understand the biology of metastatic/oligometastatic disease progression.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Prevention and Risk Reduction\r\n\t<ul>\r\n\t\t<li>Identify innovative strategies for the prevention and/or interception of lung cancer development.</li>\r\n\t\t<li>Identify innovative strategies for the prevention of recurrence or metastases from lung cancer.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Detection, Diagnosis and Surveillance\r\n\t<ul>\r\n\t\t<li>Improve and expand approaches to screening and early detection of lung cancer.</li>\r\n\t\t<li>Identify strategies for prompt detection and/or characterization of progressive disease.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Treatment and Prognosis\r\n\t<ul>\r\n\t\t<li>Identify innovative strategies for the treatment of lung cancer, including overcoming resistance.</li>\r\n\t\t<li>Develop or optimize biomarkers to assist with therapeutic decision-making.</li>\r\n\t\t<li>Enhance the understanding, detection, and treatment of brain and leptomeningeal metastases in lung cancer.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Health Outcomes and Survivorship\r\n\t<ul>\r\n\t\t<li>Identify and understand the long-term and cumulative effects of lung cancer and its treatment(s) on quality of life for patients and families.</li>\r\n\t\t<li>Identify and understand the impact of comorbidities on survivorship care in all stages of lung cancer.</li>\r\n\t\t<li>Reduce differences among high-risk groups and populations.</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>","image_description":"","creation_date":"2026-05-26T19:15:50","last_modification_date":"2026-05-26T19:15:50","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120861/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71949,"title":"U.S. CDMRP – Amyotrophic Lateral Sclerosis Research Program | Research Funding","slug":"us-cdmrp-amyotrophic-lateral-sclerosis-research--4","event_url":"https://memento.epfl.ch/event/us-cdmrp-amyotrophic-lateral-sclerosis-research--4","visual_url":"https://memento.epfl.ch/image/33257/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33257/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33257/max-size.jpg","lang":"en","start_date":"2026-06-24","end_date":"2026-06-24","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Amyotrophic Lateral Sclerosis Research Program (ALSRP) </strong>Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Clinical Outcomes and Biomarkers Award </strong>supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&amp;fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Pilot Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or symptom management of ALS. Proposed projects may range from phase 1 to small-scale phase 2 trials. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&amp;fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Therapeutic Development Award </strong>supports research ranging from preclinical validation of therapeutic leads through FDA IND-enabling studies. The proposed studies are expected to be empirical in nature and product driven. Applicants with limited ALS experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints, and pathophysiology. Candidate therapeutics that already have been granted an IND are not appropriate for the TDA.</li>\r\n\t<li>The <strong>Therapeutic Idea Award </strong>supports new, innovative, high-risk, high-gain ideas aimed at ALS drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.</li>\r\n</ul>\r\n<strong>Funding</strong>:      \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: max. $1M</li>\r\n\t<li>Pilot Clinical Trial Award: max. $2.8M</li>\r\n\t<li>Therapeutic Development Award: max. $2M</li>\r\n\t<li>Therapeutic Idea Award: max. $840K</li>\r\n</ul>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<strong>Duration</strong>:   \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: 3 years</li>\r\n\t<li>Pilot Clinical Trial Award: 3 years</li>\r\n\t<li>Therapeutic Development Award: 3 years</li>\r\n\t<li>Therapeutic Idea Award: 2 years</li>\r\n</ul>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 24 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>30 September 2026</strong>, 11:59 p.m Eastern Time<br>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=707101\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241278&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Clinical Outcomes and Biomarkers Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&amp;fileType=pdf\">HT942526ALSRPCOBA</a></li>\r\n\t\t<li>Pilot Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&amp;fileType=pdf\">HT942526ALSRPPCTA</a></li>\r\n\t\t<li>Therapeutic Development Award : <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35921227&amp;fileType=pdf\">HT942526ALSRPTDA</a></li>\r\n\t\t<li>Therapeutic Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35919305&amp;fileType=pdf\">HT942526ALSRPTIA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>","image_description":"","creation_date":"2026-05-26T19:57:31","last_modification_date":"2026-05-26T19:57:31","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120862/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71950,"title":"U.S. CDMRP – Peer Reviewed Cancer Research Program | Research Funding","slug":"us-cdmrp-peer-reviewed-cancer-research-program-res","event_url":"https://memento.epfl.ch/event/us-cdmrp-peer-reviewed-cancer-research-program-res","visual_url":"https://memento.epfl.ch/image/33258/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33258/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33258/max-size.jpg","lang":"en","start_date":"2026-06-26","end_date":"2026-06-26","start_time":null,"end_time":null,"description":"<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Peer Reviewed Cancer Research Program (PRCRP). </strong>Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Idea Award </strong>supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.</li>\r\n\t<li>The <strong>Impact Award</strong> supports mature research that will have a near-term impact on clinical cancer care in one of the Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the MHS.</li>\r\n\t<li>The <strong>Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.</li>\r\n</ul>\r\nAll applications must specifically address at least one of the <strong>Topic Areas. </strong>The FY26 PRCRP Topic Areas are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>:      <br>\r\n<strong>Idea Award</strong>: max. $600K<br>\r\n<strong>Impact Award</strong>: $1.5M-$2M<br>\r\n<strong>Clinical Trial Award</strong>: max. $4.5M<br>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<br>\r\n<strong>Duration</strong>:     <br>\r\n<strong>Idea Award</strong>: 2 years<br>\r\n<strong>Impact Award</strong>: 3 years<br>\r\n<strong>Clinical Trial Award: </strong>4 years<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 26 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>05 October 2026</strong>, 11:59 p.m Eastern Time<br>\r\n                                                           <br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719105\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36245281&amp;fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:research@epfl.ch\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235224&amp;fileType=pdf\">HT942526PRCRPIA</a></li>\r\n\t\t<li>Impact Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235237&amp;fileType=pdf\">HT942526PRCRPIPA</a></li>\r\n\t\t<li>Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235233&amp;fileType=pdf\">HT942526PRCRPCTA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<strong>FY26 </strong><strong>PRCRP Topic Areas:</strong><br>\r\nBladder cancer • Blood cancers • Brain cancer • Colorectal cancer • Endometrial cancer • Esophageal cancer • Germ cell cancers • Glioblastoma • Liver cancer • Lymphoma • Mesothelioma • Metastatic cancers • Myeloma • Neuroblastoma • Neuroendocrine Tumors • Pediatric, adolescent, and young adult cancers1 • Pediatric brain tumors • Sarcoma • Stomach cancer • Thyroid cancer<br>\r\n ","image_description":"","creation_date":"2026-05-26T20:48:08","last_modification_date":"2026-05-26T20:48:08","link_label":"","link_url":"","canceled":"False","cancel_reason":"","place_and_room":"","url_place_and_room":"","url_online_room":"","spoken_languages":["https://memento.epfl.ch/api/v1/spoken_languages/2/?format=json"],"speaker":"","organizer":"","contact":"<a href=\"mailto:research@epfl.ch\">Research Office</a>","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120863/","category":{"id":16,"code":"PROP","fr_label":"Appel à proposition","en_label":"Call for proposal","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/9/?format=json","https://memento.epfl.ch/api/v1/mementos/140/?format=json"]},{"id":71952,"title":"AI Center Seminar - AI Fundamentals series - Prof. Joseph Campbell","slug":"ai-center-seminar-ai-fundamentals-series-prof-jose","event_url":"https://memento.epfl.ch/event/ai-center-seminar-ai-fundamentals-series-prof-jose","visual_url":"https://memento.epfl.ch/image/33260/200x112.jpg","visual_large_url":"https://memento.epfl.ch/image/33260/720x405.jpg","visual_maxsize_url":"https://memento.epfl.ch/image/33260/max-size.jpg","lang":"en","start_date":"2026-06-10","end_date":"2026-06-10","start_time":"14:30:00","end_time":"15:30:00","description":"<p>The talk is jointly organized by the <a href=\"https://ai.epfl.ch/\">EPFL AI Center</a> and the EPFL <a href=\"https://search.epfl.ch/?filter=unit&amp;q=MLBIO#\">Machine Learning for Biomedicine Lab (MLBIO</a>) as part of the AI Fundamentals seminar series.<br>\r\n<br>\r\n<strong>Title</strong><br>\r\nAgents That Know What They Know: Interpretability and Introspection for Lifelong Learning<br>\r\n<br>\r\n<strong>Abstract</strong><br>\r\nOne of the hallmarks of intelligence is the ability to learn from experience. In artificial intelligence, we frame this as lifelong learning: autonomous agents that continue to adapt after deployment as they encounter new tasks and environments. In this talk, I will argue that successful lifelong learning agents require a form of introspection: they must be able to reason about the scope and limits of their own knowledge. This self-knowledge allows an agent to answer three fundamental questions. What do I know? When can I reuse what I know? And what do I still need to learn? I will present recent work from my group showing how ideas from interpretability and explainability can surface the knowledge needed to answer these questions. I will first show how learned representations can be used to identify when inputs are novel, enabling out-of-distribution detection. Then, I will discuss how this can be built upon to give agents a way to distinguish between situations where prior knowledge can be safely reused and situations where new learning is needed. Together, this work shows that interpretability is not only a tool for transparency, but a mechanism for building agents that recognize, reuse, and acquire knowledge over time.<br>\r\n<br>\r\n<strong>Bio</strong><br>\r\nJoseph Campbell is an Assistant Professor in the Department of Computer Science at Purdue University, where he leads the Collaborative AI for Machines and People Lab. His research bridges machine learning and robotics, with a focus on explainable machine learning and lifelong learning. Before joining Purdue, he was a Postdoctoral Fellow in the Robotics Institute at Carnegie Mellon University, and he received his Ph.D., M.S., and B.S. degrees from Arizona State University. His research is supported by Amazon, the Toyota Research Institute, and the National Science Foundation.</p>","image_description":"","creation_date":"2026-05-27T09:30:40","last_modification_date":"2026-05-27T09:32:39","link_label":"Zoom Link","link_url":"https://epfl.zoom.us/j/64136119684?pwd=SnvV7rbkJ6rQEaV3AUJ6vSJNaucJqo.1","canceled":"False","cancel_reason":"","place_and_room":"ELE 117","url_place_and_room":"https://plan.epfl.ch/?room==ELE%20117","url_online_room":"https://epfl.zoom.us/j/64136119684?pwd=SnvV7rbkJ6rQEaV3AUJ6vSJNaucJqo.1","spoken_languages":[],"speaker":"","organizer":"","contact":"Nicolas Machado","is_internal":"False","theme":"","vulgarization":{"id":1,"fr_label":"Tout public","en_label":"General public"},"registration":{"id":3,"fr_label":"Entrée libre","en_label":"Free"},"keywords":"","file":null,"icalendar_url":"https://memento.epfl.ch/event/export/120866/","category":{"id":1,"code":"CONF","fr_label":"Conférences - Séminaires","en_label":"Conferences - Seminars","activated":true},"academic_calendar_category":null,"domains":[],"mementos":["https://memento.epfl.ch/api/v1/mementos/6/?format=json","https://memento.epfl.ch/api/v1/mementos/27/?format=json","https://memento.epfl.ch/api/v1/mementos/416/?format=json"]}]}